Optimal administration of fosaprepitant in patients with colon cancer
Phase 2
- Conditions
- Colon Cancer
- Registration Number
- JPRN-UMIN000010181
- Lead Sponsor
- Hitachi General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who previously developed serious or irreversible adverse effects at the administration site 2) Patients who were judged to be inappropriate as subjects by the study investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain at the injection site evaluated by NRS
- Secondary Outcome Measures
Name Time Method Development site, time of development, duration of symptoms, reaction of injection site, and procedures to decrease symptoms